Susan Bobulsky

SVP, Diagnostics, clonoSEQ, Adaptive Biotechnologies.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 15, 2026Sold 1,195 shares at $27.00 of Adaptive Biotechnologies²
Aug 10, 2026Sold 3,000 shares at $25.00 of Adaptive Biotechnologies³
Jul 30, 2026Sold 1,299 shares at $24.00 of Adaptive Biotechnologies⁴
Jul 16, 2026Sold 5,000 shares at $23.00 of Adaptive Biotechnologies⁵
Jul 1, 2026Sold 487 shares at $22.00 of Adaptive Biotechnologies⁶
Jun 25, 2026Sold 5,000 shares at $20.50 of Adaptive Biotechnologies⁷
Jun 11, 2026Sold 5,000 shares at $19.00 of Adaptive Biotechnologies⁸
Jun 4, 2026Sold 11,000 shares at $18.00 of Adaptive Biotechnologies⁹
Mar 11, 2026Sold 41,338 shares at $13.17 of Adaptive Biotechnologies¹⁰
Mar 4, 2026Granted 62,500 shares of Adaptive Biotechnologies¹¹
Mar 4, 2026Granted 59,375 shares of Adaptive Biotechnologies¹¹
Mar 5, 2025Sold 26,023 shares at $6.98 of Adaptive Biotechnologies¹²
Mar 4, 2025Granted 119,971 shares of Adaptive Biotechnologies¹²
Oct 8, 2024Exercised options 5,000 shares at $1.98 of Adaptive Biotechnologies¹³
Mar 5, 2024Sold 6,975 shares at $3.44 of Adaptive Biotechnologies¹⁴
Mar 5, 2024Sold 6,016 shares at $3.43 of Adaptive Biotechnologies¹⁴
Mar 4, 2024Granted 132,979 shares of Adaptive Biotechnologies¹⁴

The numbers on this page point here. Each one links to the record it came from.